PD-L1 Expression Correlates With Tumor Infiltrating Lymphocytes And Response To Neoadjuvant Chemotherapy In Cervical Cancer

Programmed death-ligand 1 (PD-L1) has been reported to be expressed in many types of tumor cells, and bind to PD-1 on T lymphocytes to inhibit immune response. Immunologic checkpoint blockade with antibodies that target the PD1/PD-L1 pathway has demonstrated to have impressive antitumor effects on m...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Ying, Liang, Huyi, Hu, Jianguo, Liu, Shuaibin, Hao, Xiaoming, Wong, Micheal Sze Ka, Li, Xiaoyi, Hu, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096364/
https://www.ncbi.nlm.nih.gov/pubmed/30123362
http://dx.doi.org/10.7150/jca.22532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096364/
https://www.ncbi.nlm.nih.gov/pubmed/30123362
http://dx.doi.org/10.7150/jca.22532

Ejemplares similares